Beacon Biosignals announces the FDA authorization of the Predetermined Change Control Plan for the Dreem 3S, allowing for continuous algorithm enhancements in sleep monitoring. This wearable EEG headband offers a clinically validated alternative to in-lab sleep studies and aims to improve diagnosis and treatment for sleep-related CNS diseases.
Company Information
Company
Beacon Biosignals
Location
80 REVERE ST., #10
Boston, Massachusetts, United States
About
Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Biosignals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonInformation TechnologySoftware